companydata.dkcompanydata.dk

PHARMAVIE A/S: Financial statements 2025

CVR: 26553148

Source: annual report 2025, Danish Business Authority

01/01/2025 – 31/12/2025

PHARMAVIE A/S (CVR 26553148) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK 172,767 and a net result of DKK 821,439 compared with DKK 1,603,686 the year before. That is a decrease of 57.7% compared with the year before. Equity in the 2025 report amounted to DKK -978,681. The company had 1 employee in the financial year.

Gross Profit
DKK 172,767
Profit/Loss
DKK 821,439
Equity
DKK -978,681
Total Assets
DKK 9,159,781
Employees
1

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2025-173K821K-979K1
2024-408K1.6M-1.8M1
2023-335K-4.4M-3.4M1
2022-331K-1.1M990K1
2021-246K1.4M2.1M-

Official annual report

View the official annual report directly on the page with a Pro subscription.

How creditworthy is PHARMAVIE A/S?

See the CDS score and get a full credit report with recommended credit limit and payment terms.

Read about the CDS score

Events in 2025

PHARMAVIE A/S: The 2024 annual report is outMay 19, 2025

PHARMAVIE A/S has published its annual report for 2024. Gross profit came to DKK 408,416, and the net result was DKK 1,603,686.

About PHARMAVIE A/S

PHARMAVIE A/S is a Danish company of the type Aktieselskab based in Greve, founded in 2002. The company is registered under the industry Virksomhedsrådgivning og anden ledelsesrådgivning. The company was previously named PHARMAVIE CONSULT A/S. The management consists of Carsten Wærn. The board consists of Margit Wærn (chair), Carsten Wærn and Vibeke Wærn. The company is owned by MAW HOLDING ApS and VIPS HOLDING ApS. The company has 1 employee (2025). In 2025, the company reported a gross profit of DKK 172,767 and a net result of DKK 821,439 compared with DKK 1,603,686 the year before. Equity in the 2025 report amounted to DKK -978,681.

Source: annual report 2025, Danish Business Authority